Medical News

Black Philadelphians contract the coronavirus at a rate nearly twice that of their white counterparts. They also are more likely to have severe cases of the virus: African Americans make up 44% of Philadelphians but 55% of those hospitalized for COVID-19.

A new, international clinical trial is underway that assesses inhaled nitric oxide as a treatment for patients with mild to moderate cases of COVID-19.

A surgical mask does not provide the wearer with a reliable level of protection from inhaling smaller airborne particles and is not considered respiratory protection.

When inhaling through the nose, your nasal nitric oxide is inhaled into your lungs, where it stands a chance of meeting up with the virus particles. Inhaling through your mouth will NOT accomplish this.

The FDA issued a formal warning to consumers that hydroxychloroquine and chloroquine -- the antimalarial drugs touted by President Trump as a cure-all for COVID-19 -- should not be used outside of a hospital setting to treat the novel coronavirus.

A new study conducted by the V.A. found that patients using hydroxychloroquine, the anti-malaria drug highly promoted by President Trump as a cure-all for COVID-19, had higher rates of death compared with those not using the drug.

Climate change presents many threats across the country: Heat stress can exacerbate mental illness; Air pollution worsens respiratory problems; High temperatures can weaken the effectiveness of medications. But is the topic too political for the exam room?

“This absolutely does not mean the pandemic is nearing an end,” according to an infectious disease expert. “Once you get past the peak, it’s not over until it’s over. It’s just the starting time for the rest of the response.”

Expect Round 2 of the coronavirus battle to return next Winter. As the U.S. nears the peak of the COVID-19 crisis, Dr. Robert Redfield, Director of the Centers for Disease Control and Prevention, is already expecting another big hit of the virus before the end of the year.

A new study found that chloroquine should not be used in higher dosages to treat COVID-19 due to potential harm to patients, specifically fatal heart arrhythmia.